Vitamin-targeted imaging agents
US8834842B2 · kind B2 · utility
30Cited by
14References
69Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2013 |
| Grant date | Sep 16, 2014 |
| Priority date | — |
| Expiry date | Mar 11, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/088
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds and methods for targeting radionuclide-based imaging agents to cells having receptors for a vitamin, or vitamin receptor binding derivative or analog thereof, by using such a vitamin as the targeting ligand for the imaging agent.The vitamin-based compounds can be used to target radionuclides to cells, such as a variety of tumor cell types, for use in diagnostic imaging of the targeted cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.